Pfizer responds to Trump’s criticism on COVID success; to share data for new COVID shot

2 days ago 1

Healthcare

Comments
(4)

Pfizer Makes $1.95 Billion Deal With U.S. For Future COVID-19 Vaccine

Responding to President Donald Trump’s recent criticism that drug companies have yet to justify the success of their COVID products, Pfizer (NYSE:PFE) announced on Wednesday plans to share new data related to its updated COVID shot developed with BioNTech (

Recommended For You

Read Entire Article

Pfizer responds to Trump’s criticism on COVID success; to share data for new COVID shot

Recommended For You

Related

Argan stock drops as revenue misses estimates; backlog and p...

Market Voices: Job number revisions, Hyundai ICE raid, DOD n...

Alibaba in focus as Qwen unveils preview of new AI model wit...

Legend Biotech considering second stock listing outside US

AMD, Nvidia slump as Broadcom gets new customer for AI chip

Halliburton cuts workforce as oil activity slumps - Reuters

Network-1 Technologies declares $0.05 dividend

Verizon raises dividend by 1.8% to $0.69

Tri-Continental Cum.Pref.Shs declares $0.625 dividend

Tri-Continental declares $0.2654 dividend

McRae declares $0.14 dividend

As AI makes it harder to land a job, OpenAI is building a pl...

Ocular Therapeutix gains amid takeover speculation

Nvidia CEO Jensen Huang sent research reports on Sundays to ...

Google hit with nearly $3.5B fine in Europe over ad-tech

Pullback presents buying opportunities as market will resume...

Fastenal falls after August daily sales growth rate declined...

US unemployment worsens to 4.3% in August, but in line with ...

The Trump administration flubbed a detail on its Japan trade...

Abivax jumps amid takeover speculation

Trending

Popular

ETH transactions hit year high, $2.7B BTC whale meltdown: Au...

England bowled out inside 25 overs in ODI hammering by South...